أعلنت شركة #GSR عن الاستحواذ على شركتي #Autonomous و #Architech لإطلاق منصة متكاملة لأسواق رأس المال والخزانة في قطاع الكريبتو. #CapitalMarkets #M_A

23. The essential intermediary between risk and security For our twenty-third episode, we're talking about insurance. [pause] Okay, okay, stick with me! [chuckles] I know it doesn't sound exciting, but what if I told you there was a way to profit from the massive, essential insurance industry without taking the risk of a hurricane, a flood, or a wildfire? Today's company is not an insurance company. They are an insurance broker. They are the expert guides, the trusted advisors who help businesses navigate the complex world of risk. They are the ultimate middleman in a multi-trillion dollar industry. We are talking about the incredibly successful, family-led compounding machine... Brown & Brown. When you think of major players in the financial world, insurance brokers might not be the first to come to mind. But Brown & Brown ($BRO), one of the largest and most successful insurance brokerage firms in the world, tells a powerful story of consistent growth. For decades, their core business has been the unglamorous but incredibly steady work of connecting businesses and individuals with the right insurance products, from property and casualty to employee benefits. The real engine behind Brown & Brown’s success, however, is its relentless and disciplined acquisition strategy. The company has a long history of buying up smaller insurance agencies and integrating them into its decentralized, entrepreneurial culture. This has turned Brown & Brown into a compounding machine, quietly consolidating a fragmented industry. But in an increasingly digital world, can this old-school model of growth through acquisition continue to deliver market-beating returns? We're examining the fine print to see if Brown & Brown's stock is a reliable policy for a long-term portfolio.

📣 New Podcast! "23. The essential intermediary between risk and security" on @Spreaker #acquisitions #bro #brokerage #brown_brown #commercial #compounder #corporate #defensive #dividends #finance #financials #growth #insurance #investing #m_a #management #portfolio #risk #services #stock

22. The company that created BIO in biotechnology For our twenty-second episode, we’re heading into the laboratory. We're going to talk about a company that was one of the original pioneers of the biotechnology revolution. They don't make pills out of chemicals... no... they harness the power of living cells to create complex biologic drugs that can treat some of the most difficult diseases on Earth, from cancer to kidney failure to autoimmune disorders. We are talking about one of the founding fathers of biotech... Amgen. When you hear the name Amgen ($AMGN), you probably think of a pioneering biotech firm, one of the original giants of the industry. For decades, it has been a dominant force in medicine, developing blockbuster drugs for everything from arthritis to cancer and high cholesterol. Amgen is the undisputed king of mature biotechnology, a blue-chip stock in the Dow Jones Industrial Average known for its massive cash flows and shareholder returns. But in an industry defined by innovation, the biggest threat comes from within: patent expirations. With key drugs facing increasing competition from biosimilars, Amgen is in a race against time to refresh its portfolio. The company has responded with major acquisitions, like the nearly $28 billion purchase of Horizon Therapeutics, to bolster its pipeline of new drugs. Can Amgen’s aggressive M&A strategy and its own research and development successfully navigate the looming patent cliff, or is this defensive stalwart facing a period of slow growth? We're looking under the microscope to determine if Amgen's pipeline has the cure for its patent woes, making it a healthy addition to your portfolio.

📣 New Podcast! "22. The company that created BIO in biotechnology" on @Spreaker #amgen #amgn #analysis #biotech #bluechip #dividend #drugs #enbrel #finance #healthcare #horizon #investing #m_a #market #patent #pharma #pipeline #portfolio #stocks #valuation

11. Buying boring Software Companies For our eleventh episode, we're going off the beaten path to look at a company you've likely never heard of, but whose performance would make the tech gods of Silicon Valley blush. This company doesn't have a flashy product... it doesn't have a charismatic CEO on magazine covers... its headquarters are in Toronto, Canada, not California. Its genius lies not in a single invention, but in a relentless, disciplined process. It has often been called the "Berkshire Hathaway of Software." We are talking about the ultimate under-the-radar compounding machine... Constellation Software. While most software companies focus on building the next big thing, Canada's Constellation Software ($CSU.TO) has quietly become one of the best-performing stocks in the world by doing the exact opposite. Led by the brilliant and reclusive capital allocator Mark Leonard, Constellation is a master acquirer. Their strategy is simple yet powerful: buy hundreds of small, durable, and mission-critical software businesses in niche markets, and use their cash flows to buy even more. This disciplined approach has created a compounding machine that has delivered truly staggering returns for decades. But as Constellation grows into a corporate giant, the challenge of finding enough quality acquisitions at reasonable prices becomes ever more difficult. With the stock trading at a perpetual premium and facing increased competition for deals, is the golden era of hyper-growth over? We're decompiling the code of this unique business to determine if the Constellation Software compounding story can continue to shine for investors.

📣 New Podcast! "11. Buying boring Software Companies" on @Spreaker #acquirer #analysis #canadian #capital #compounder #constellation #csu #decentralized #finance #investing #leonard #m_a #market #niche #portfolio #software #stocks #tech #valuation #vms

Μάντσεστερ Γιουνάιτεντ: Επιστροφή Μαγκουάιρ και Γιόρο ενόψει Νότιγχαμ Γεμίζει το... οπλοστάσιο του Αμορίμ

#M_a #Γιόρο